Coinfections and antimicrobial treatment in a cohort of falciparum malaria in a non-endemic country: a 10-year experience
-
Published:2023-10-27
Issue:
Volume:
Page:
-
ISSN:0300-8126
-
Container-title:Infection
-
language:en
-
Short-container-title:Infection
Author:
Küpper-Tetzel Claus P.,Idris Raja,Kessel Johanna,Schüttfort Gundolf,Hoehl Sebastian,Kohmer Niko,Graf Christiana,Hogardt Michael,Besier Silke,Wichelhaus Thomas A.,Vehreschild Maria J. G. T.,Stephan Christoph,Wetzstein Nils
Abstract
Abstract
Introduction
Falciparum malaria remains one of the deadliest infectious diseases worldwide. In Germany, it is mainly an imported infection among travellers. Rates of coinfection are often unknown, and a clinical rationale for the beneficial use of calculated antibiotic therapy in patients with malaria and suspected coinfection is lacking.
Methods
We conducted an analysis of all in-patients treated with falciparum malaria at a German infectious diseases centre in vicinity to one of Europe’s major airports for 2010–2019. Logistic regression and time-to-event analysis were used to evaluate predictors for bacterial coinfection, the use of antibacterial substances, as well as their influence on clinical course.
Results
In total, 264 patients were included. Of those, 64% received an additional antibacterial therapy (n = 169). Twenty-nine patients (11.0%) were found to have suffered from a relevant bacterial coinfection, while only a small fraction had relevant bacteremia (n = 3, 1.4%). However, patients with severe malaria did not suffer from coinfections more frequently (p = 0.283). CRP levels were not a reliable predictor for a bacterial coinfection (OR 0.99, 95% CI 0.94–1.06, p = 0.850), while another clinical focus of infection was positively associated (OR 3.86, 95% CI 1.45–11.55, p = 0.010).
Conclusion
Although bacterial coinfections were rare in patients with malaria at our centre, the risk does not seem negligible. These data point rather towards individual risk assessment in respective patients than to general empiric antibiotic use.
Funder
Johann Wolfgang Goethe-Universität, Frankfurt am Main
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference30 articles.
1. WHO Guidelines for malaria. WHO Guidelines for malaria. World Health Organization; 2021. http://www.ncbi.nlm.nih.gov/pubmed/33724744. Accessed 29 Mar 2021
2. Boualam MA, Pradines B, Drancourt M, Barbieri R. Malaria in Europe: A Historical Perspective. Front Med. 2021. https://doi.org/10.3389/FMED.2021.691095.
3. Rapid risk assessment: Multiple reports of locally-acquired malaria infections in the EU. https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-multiple-reports-locally-acquired-malaria-infections-eu. Accessed 20 Jan 2023
4. Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2020. 2020.
5. Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2011. 2012.